Top stock movers — RIL, SpiceJet, Titan, Tech Mahindra, Vodafone Idea, Gland Pharma, Bharat Electronics, and others

• The 30-share BSE index was trading 0.34% higher, and the broader NSE Nifty was trading points 39 higher on Friday at 10:40 am.
• Here’s a list of the top losers and gainers in the Nifty pack.
• These are the top stocks that are buzzing in trade today.
• $4

Indian equity benchmark indices surged in early trade on Friday, tracking gains in index-heavyweights HDFC twins, Kotak Bank and Bajaj Finance amid largely positive cues from global markets and sustained foreign fund inflow.

The 30-share BSE index was trading 0.34% higher, and the broader NSE Nifty was trading points 39 higher on Friday at 10:40 am.

Here’s a list of the top losers and gainers in the Nifty pack.

Top Nifty Gainers	Top Nifty Losers
Bajaj Finserv	IndusInd Bank
Titan	RIL
Nestle India	UPL
Tech Mahindra	Axis Bank
NTPC	ICICI Bank

*as of November 20, 10:35 am

These are the top stocks in news today.

SpiceJet extends gain for the second day

SpiceJet shares gained over 5% — extending gains for the second day in a row after the US FAA cleared Boeing’s 737 Max aircraft to resume flying. 737 Max aircraft were banned nearly two years ago after two fatal crashes. SpiceJet has a fleet of 13 such planes that were grounded in March 2019.

Vodafone Idea gains nearly 5%

The shares of Vodafone Idea soared 5% after receiving cash consideration of ₹3,760.1 crore for its 11.15% shareholding in Indus, post the completion of the much-delayed merger of Bharti Infratel and Indus Towers on Thursday.

Mphasis up nearly 3%

The shares of IT firm Mphasis gained over nearly 3% after its subsidiary, Mphasis Consulting, acquired UK-based Datalytyx for up to £13.3 million (about ₹130.4 crore).

The acquisition is expected to provide access to strengthen Mphasis next-generation Data GTM Strategy and provide higher value partnership status with Snowflake and Talend for cloud-based data services, a regulatory filing said.

Gland Pharma stellar debut

The shares of Gland Pharma listed at a premium of 12% over the issue price band on the Indian stock exchanges. The shares gained nearly 7% post listing, in minutes after debut.

Bharat Electronics surges 5%

The shares of Bharat Electronics surged 5% post strong management guidance and brokerages remain bullish on the stock. Jefferies has maintained its “buy” rating with a target of ₹130 per share.

SEE ALSO: $4

FOMO helps Gland Pharma swell on debut>$4